Sort by
Refine Your Search
-
Listed
-
Category
-
Employer
- University of East Anglia
- University of Nottingham
- NORTHUMBRIA UNIVERSITY
- Newcastle University
- The Institute of Cancer Research
- The University of Edinburgh;
- The University of Manchester;
- University of Birmingham
- University of Exeter
- University of Hertfordshire
- University of Newcastle
- University of Surrey
- 2 more »
- « less
-
Field
-
PhD studentship in Computational Chemistry – Training force fields for computer-aided drug design with machine learning. Award Summary 100% fees covered, and a minimum tax-free annual living
-
the side effects that are often seen with classical cancer drugs? Over the years there have been a number of approaches to developing targeting methods. We have previously used peptides to generate molecules
-
), patent applications and commercialisation (e.g. UoE spinout, MitoRx Therapeutics ). Here, you will design, synthesise and characterise novel potential drug structures to target intracellular structures
-
-the-fitness-costs-of-drug-resistance-in-cancer for further information. The project aims include: Project aims Barcode a panel of cancer cell lines to enable genetic lineage tracing Design a large-scale
-
explore ways to control their motion in 3D space. Synthetic microswimmers have many potential biomedical applications, including targeted drug delivery and non-invasive medical treatments. The swimmers
-
5 Oct 2025 - 00:00 (UTC) Type of Contract Other Job Status Full-time Is the job funded through the EU Research Framework Programme? Not funded by a EU programme Is the Job related to staff position
-
Advances in manufacturing science have resulted in unprecedented research and development in the design of ‘micro-swimmers’: microscopic entities that navigate fluid environments by converting some
-
(chemical biology and pharmacology). The student will also undertake a three-month placement at Prozomix Ltd., gaining industrial experience in enzyme production, assay design, and biocatalytic process
-
] Oligonucleotide therapeutics are an emergent drug modality and consist of modified or unmodified short nucleic acid sequences; these include antisense oligonucleotides (ASOs), small interfering RNA (siRNAs
-
Programme Description The Centre for MoDDD at the University of Hertfordshire invites applications for a PhD candidate to join a 3-year QR-funded research project on repurposing drugs against